Top

Infection

Published in:

30-04-2022 | Long-COVID Syndrome | Review

Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism

Authors: Anushri Umesh, Kumar Pranay, Ramesh Chandra Pandey, Mukesh Kumar Gupta

Published in: Infection | Issue 5/2022

Abstract

Purpose

Apart from the global disease burden of acute COVID-19 disease, the health complications arising after recovery have been recognized as a long-COVID or post-COVID-19 syndrome. Evidences of long-COVID symptoms involving various organ systems are rapidly growing in literature. The objective was to perform a rapid review and evidence mapping of systemic complications and symptoms of long-COVID and underlying pathophysiological mechanisms.

Methods

Publications reporting clinical trials, observational cohort studies, case–control studies, case-series, meta-analysis, and systematic reviews, focusing on the squeal of the disease, consequences of COVID-19 treatment/hospitalization, long-COVID, chronic COVID syndrome, and post acute COVID-19 were reviewed in detail for the narrative synthesis of frequency, duration, risk factors, and pathophysiology.

Results

The review highlights that pulmonary, neuro-psychological, and cardiovascular complications are major findings in most epidemiological studies. However, dysfunctional gastrointestinal, endocrine, and metabolic health are recent findings for which underlying pathophysiological mechanisms are poorly understood. Analysis of the clinical trial landscape suggests that more than 50% of the industry-sponsored trials are focused on pulmonary symptoms. In contrast to the epidemiological trends and academic trials, cardiovascular complications are not a focus of industry-sponsored trials, suggestive of the gaps in the research efforts.

Conclusion

The gap in epidemiological trends and academic trials, particularly concerning cardiovascular complications not being a focus of industry-sponsored trials is suggestive of the gaps in research efforts and longer follow-up durations would help identify other long-COVID-related health issues such as reproductive health and fertility.

Available only for authorised users

Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS ONE. 2021;16: e0249644. https://doi.org/10.1371/journal.pone.0249644.CrossRefPubMedPubMedCentral

Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021. https://doi.org/10.1007/s12016-021-08848-3.CrossRefPubMedPubMedCentral

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv Prepr Serv Heal Sci. 2021. https://doi.org/10.1101/2021.01.27.21250617.CrossRef

Fernández-de-Las-Peñas C, Torres-Macho J, Velasco-Arribas M, Arias-Navalón JA, Guijarro C, Hernández-Barrera V, et al. Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study. J Infect. 2021;83:237–79. https://doi.org/10.1016/j.jinf.2021.04.034CrossRefPubMedPubMedCentral

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626–31. https://doi.org/10.1038/s41591-021-01292-y.CrossRefPubMedPubMedCentral

Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021. https://doi.org/10.1016/j.arcmed.2021.03.010.CrossRefPubMedPubMedCentral

Cabrera Martimbianco AL, Pacheco RL, Bagattini ÂM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75: e14357. https://doi.org/10.1111/ijcp.14357.CrossRefPubMed

Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a mediterranean cohort study. J Infect. 2021;82:378–83. https://doi.org/10.1016/j.jinf.2021.01.004.CrossRefPubMedPubMedCentral

Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28–33. https://doi.org/10.1038/s41591-020-01202-8.CrossRefPubMed

10.

Benzakour L, Assal F, Péron JA. Neuropsychological long-COVID: neurologic or psychiatric origin? Rev Med Suisse. 2021;17:822–6.PubMed

11.

Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–5. https://doi.org/10.1001/jama.2020.12603.CrossRefPubMedPubMedCentral

12.

De Lorenzo R, Conte C, Lanzani C, Benedetti F, Roveri L, Mazza MG, et al. Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study. PLoS ONE. 2020;15: e0239570. https://doi.org/10.1371/journal.pone.0239570.CrossRefPubMedPubMedCentral

13.

D’Cruz RF, Waller MD, Perrin F, Periselneris J, Norton S, Smith L-J, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7:00655–2020. https://doi.org/10.1183/23120541.00655-2020.CrossRefPubMedPubMedCentral

14.

Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4-6. https://doi.org/10.1016/j.jinf.2020.08.029.CrossRefPubMedPubMedCentral

15.

Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27:89–95. https://doi.org/10.1016/j.cmi.2020.09.023.CrossRefPubMed

16.

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–27. https://doi.org/10.1016/S2215-0366(21)00084-5.CrossRefPubMedPubMedCentral

17.

Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A, et al. Post-COVID 19 neurological syndrome: implications for sequelae’s treatment. J Clin Neurosci. 2021;88:219–25. https://doi.org/10.1016/j.jocn.2021.04.001.CrossRefPubMedPubMedCentral

18.

Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, et al. Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. 2021;90:315–8. https://doi.org/10.1002/ana.26144.CrossRefPubMed

19.

Park S, Majoka H, Sheikh A, Ali I. A presumed case of new-onset focal seizures as a delayed complication of COVID-19 infection. Epilepsy Behav Reports. 2021;16: 100447. https://doi.org/10.1016/j.ebr.2021.100447.CrossRef

20.

Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, et al. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020;61:e135–9. https://doi.org/10.1111/epi.16683.CrossRefPubMedPubMedCentral

21.

Aasfara J, Hajjij A, Bensouda H, Ouhabi H, Benariba F. A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report. Pan Afr Med J. 2021;38:30. https://doi.org/10.11604/pamj.2021.38.30.27646.CrossRefPubMedPubMedCentral

22.

Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep. 2020;13: e238419. https://doi.org/10.1136/bcr-2020-238419.CrossRefPubMedPubMedCentral

23.

Moreno-Escobar MC, Kataria S, Khan E, Subedi R, Tandon M, Peshwe K, et al. Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: a case report and review of literature. J Neuroimmunol. 2021;353: 577523. https://doi.org/10.1016/j.jneuroim.2021.577523.CrossRefPubMedPubMedCentral

24.

Décary S, Gaboury I, Poirier S, Garcia C, Simpson S, Bull M, et al. Humility and acceptance: working within our limits with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. J Orthop Sport Phys Ther. 2021;51:197–200. https://doi.org/10.2519/jospt.2021.0106.CrossRef

25.

Guedj E, Lazarini F, Morbelli S, Ceccaldi M, Hautefort C, Kas A, et al. Long COVID and the brain network of Proust’s madeleine: targeting the olfactory pathway. Clin Microbiol Infect. 2021. https://doi.org/10.1016/j.cmi.2021.05.015.CrossRefPubMedPubMedCentral

26.

Chiveri L, Verrengia E, Muscia F, Nuzzaco G, Raimondi E, Vecchio E, et al. Limbic encephalitis in a COVID-19 patient? J Neurovirol. 2021;27:498–500. https://doi.org/10.1007/s13365-021-00971-3.CrossRefPubMedPubMedCentral

27.

Catani M, Dell’acqua F, Thiebaut de Schotten M. A revised limbic system model for memory, emotion and behaviour. Neurosci Biobehav Rev. 2013;37:1724–37. https://doi.org/10.1016/j.neubiorev.2013.07.001.CrossRefPubMed

28.

Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1201–13. https://doi.org/10.1016/j.pnpbp.2005.08.006.CrossRefPubMed

29.

Roxo MR, Franceschini PR, Zubaran C, Kleber FD, Sander JW. The limbic system conception and its historical evolution. Sci World J. 2011;11:2428–41. https://doi.org/10.1100/2011/157150.CrossRef

30.

Jo HJ, Kenney-Jung DL, Balzekas I, Welker KM, Jones DT, Croarkin PE, et al. Relationship between seizure frequency and functional abnormalities in limbic network of medial temporal lobe epilepsy. Front Neurol. 2019;10:488. https://doi.org/10.3389/fneur.2019.00488.CrossRefPubMedPubMedCentral

31.

Ardila A, Lahiri D. Executive dysfunction in COVID-19 patients. Diabetes Metab Syndr. 2020;14:1377–8. https://doi.org/10.1016/j.dsx.2020.07.032.CrossRefPubMedPubMedCentral

32.

Clark JR, Liotta EM, Reish NJ, Shlobin NA, Hoffman SC, Orban ZS, et al. Abnormal movements in hospitalized COVID-19 patients: a case series. J Neurol Sci. 2021;423: 117377. https://doi.org/10.1016/j.jns.2021.117377.CrossRefPubMedPubMedCentral

33.

de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021;17:1056–65. https://doi.org/10.1002/alz.12255.CrossRefPubMed

34.

Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, et al. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. bioRxiv Prepr Serv Biol. 2021. https://doi.org/10.1101/2021.03.15.435423.CrossRef

35.

Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27:328–37. https://doi.org/10.1016/j.pulmoe.2020.10.013.CrossRefPubMed

36.

Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259–64. https://doi.org/10.1038/s41586-021-03553-9.CrossRefPubMed

37.

Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R. Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect Dis. 2021;21: e72. https://doi.org/10.1016/S1473-3099(20)30582-X.CrossRefPubMed

38.

Garcia-Pachon E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, Baeza-Martinez C, Ruiz-Alcaraz S, et al. Low prevalence of post-COVID-19 syndrome in patients with asthma. J Infect. 2021;82:276–316. https://doi.org/10.1016/j.jinf.2021.03.023.CrossRefPubMedPubMedCentral

39.

Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21:319–29. https://doi.org/10.1038/s41577-021-00536-9.CrossRefPubMedPubMedCentral

40.

Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, et al. The cardiovascular aspect of COVID-19. Ann Med. 2021;53:227–36. https://doi.org/10.1080/07853890.2020.1861644.CrossRefPubMed

41.

Johansson M, Ståhlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Reports. 2021;3:573–80. https://doi.org/10.1016/j.jaccas.2021.01.009.CrossRefPubMedPubMedCentral

42.

Ali UA, Sadiq MS, Yunus MJ. Cardiorenal syndrome in COVID-19. BMJ Case Rep. 2021;14:e241914. http://casereports.bmj.com/content/14/4/e241914.abstract. https://doi.org/10.1136/bcr-2021-241914.

43.

Farouk SS, Fiaccadori E, Cravedi P, Campbell KN. COVID-19 and the kidney: what we think we know so far and what we don’t. J Nephrol. 2020;33:1213–8. https://doi.org/10.1007/s40620-020-00789-y.CrossRefPubMedPubMedCentral

44.

Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32:151–60. https://doi.org/10.1681/ASN.2020050615.CrossRefPubMed

45.

Zhao Y-M, Shang Y-M, Song W-B, Li Q-Q, Xie H, Xu Q-F, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25: 100463. https://doi.org/10.1016/j.eclinm.2020.100463.CrossRefPubMedPubMedCentral

46.

Livanos AE, Jha D, Cossarini F, Gonzalez-Reiche AS, Tokuyama M, Aydillo T, et al. Gastrointestinal involvement attenuates COVID-19 severity and mortality. medRxiv 2020;2020.09.07.20187666. http://medrxiv.org/content/early/2020/11/11/2020.09.07.20187666.abstract. https://doi.org/10.1101/2020.09.07.20187666.

47.

Balaphas A, Gkoufa K, Meyer J, Peloso A, Bornand A, McKee TA, et al. COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall. J Hepatol. 2020;73:1566–8. https://doi.org/10.1016/j.jhep.2020.08.020.CrossRefPubMedPubMedCentral

48.

Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116:1077–82. https://doi.org/10.14309/ajg.0000000000001154.CrossRefPubMed

49.

Alhassan SM, Iqbal P, Fikrey L, Mohamed Ibrahim MI, Qamar MS, Chaponda M, et al. Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report. Ann Med Surg. 2020;60:434–7. https://www.sciencedirect.com/science/article/pii/S2049080120304581https://doi.org/10.1016/j.amsu.2020.11.031

50.

Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. New-onset diabetes in COVID-19. N Engl J Med. 2020;383:789–90. https://doi.org/10.1056/NEJMc2018688.CrossRefPubMed

51.

Sathish T, Anton MC, Sivakumar T. New-onset diabetes in “long COVID.” J Diabetes. 2021;13:693–4. https://doi.org/10.1111/1753-0407.13187.CrossRefPubMed

52.

Landstra CP, de Koning EJP. COVID-19 and diabetes: understanding the interrelationship and risks for a severe course. Front Endocrinol (Lausanne). 2021;12:649525. https://doi.org/10.3389/fendo.2021.649525.CrossRef

53.

Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, et al. COVID-19 and the endocrine system: a comprehensive review on the theme. J Clin Med. 2021;10:2920. https://doi.org/10.3390/jcm10132920.CrossRefPubMedPubMedCentral

54.

Mehmood MA, Bapna M, Arshad M. A case of post-COVID-19 subacute thyroiditis. Cureus. 2020;12: e12301. https://doi.org/10.7759/cureus.12301.CrossRefPubMedPubMedCentral

55.

Davoodi L, Oladi Z, Jafarpour H, Zakariaei Z, Soleymani E, Razavi A. A 33-year-old man with COVID-19 presented with subacute thyroiditis: a rare case report and literature review. New Microbes New Infect. 2021;41: 100871. https://doi.org/10.1016/j.nmni.2021.100871.CrossRefPubMedPubMedCentral

56.

Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case Rep Endocrinol. 2020;2020:8891539. https://doi.org/10.1155/2020/8891539.CrossRefPubMedPubMedCentral

57.

Duarte-Neto AN, Monteiro RAA, da Silva LFF, Malheiros DMAC, de Oliveira EP, Theodoro-Filho J, et al. Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy. Histopathology. 2020;77:186–97. https://doi.org/10.1111/his.14160.CrossRefPubMedPubMedCentral

58.

Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3: e208292. https://doi.org/10.1001/jamanetworkopen.2020.8292.CrossRefPubMedPubMedCentral

59.

Li Y, Wan X, Xiao Q, Zhang Y, Sun W, Xie Y, et al. Value of 3D versus 2D speckle-tracking echocardiography for rv strain measurement: validation with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2020;13:2056–8. https://doi.org/10.1016/j.jcmg.2020.04.016.CrossRefPubMed

60.

He Y, Wang J, Ren J, Zhao Y, Chen J, Chen X. Effect of COVID-19 on Male reproductive system—a systematic review. Front Endocrinol (Lausanne). 2021;12:677701. https://doi.org/10.3389/fendo.2021.677701.CrossRef

61.

Pazir Y, Eroglu T, Kose A, Bulut TB, Genc C, Kadihasanoglu M. Impaired semen parameters in patients with confirmed SARS-CoV-2 infection: a prospective cohort study. Andrologia. 2021;53:1–6. https://doi.org/10.1111/and.14157.CrossRef

62.

Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, et al. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril. 2020;114:233–8. https://doi.org/10.1016/j.fertnstert.2020.05.028.CrossRefPubMedPubMedCentral

63.

Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol. 2021;93:456–62. https://doi.org/10.1002/jmv.26259.CrossRefPubMed

64.

Tian Y, Zhou L-Q. Evaluating the impact of COVID-19 on male reproduction. Reproduction. 2021;161:R37-44. https://doi.org/10.1530/REP-20-0523.CrossRefPubMed

65.

Abdelhamid MHM, Fellah AA, Elmarghani A, Al msellati IA. An assessment of men semen alterations in SARS-CoV-2: is fever the principal concern? Reprod Sci. 2022. https://doi.org/10.1007/s43032-022-00889-z.CrossRefPubMed

66.

Schroeder M, Schaumburg B, Müller Z, Parplys A, Jarczak D, Nierhaus A, et al. Sex hormone and metabolic dysregulations are associated with critical illness in male Covid-19 patients. medRxiv 2020;2020.05.07.20073817. http://medrxiv.org/content/early/2020/12/20/2020.05.07.20073817.abstract. https://doi.org/10.1101/2020.05.07.20073817.

67.

Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology. 2021;9:88–98. https://doi.org/10.1111/andr.12821.CrossRefPubMed

68.

Agarwal M, Basumatary S, Bhusan D, Pati BK. Detection of severe acute respiratory syndrome corona virus 2 in cervico-vaginal secretion of COVID-19-affected female: a prospective observational study from India. SAGE Open Med. 2021;9:20503121211022990. https://doi.org/10.1177/20503121211022993.CrossRef

69.

Khoiwal K, Kalita D, Shankar R, Kumari R, Dhundi D, Bahadur A, et al. Identification of SARS-CoV-2 in the vaginal fluid and cervical exfoliated cells of women with active COVID-19 infection: a pilot study. Int J Gynaecol Obstet. 2021;153:551–3. https://doi.org/10.1002/ijgo.13671.CrossRefPubMedPubMedCentral

70.

Li F, Lu H, Zhang Q, Li X, wang T, Liu Q, et al. Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol. BMJ Open 2021;11:e045524. http://bmjopen.bmj.com/content/11/2/e045524.abstract. https://doi.org/10.1136/bmjopen-2020-045524

71.

Strope JD, PharmD CHC, Figg WD. TMPRSS2: potential biomarker for COVID-19 outcomes. J Clin Pharmacol. 2020;60:801–7. https://doi.org/10.1002/jcph.1641.CrossRefPubMedPubMedCentral

72.

Funke-Chambour M, Bridevaux P-O, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C. Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Respiration 2021. https://www.karger.com/. https://doi.org/10.1159/000517255.

73.

McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21:313–4. https://doi.org/10.1016/S1473-3099(20)30986-5.CrossRefPubMedPubMedCentral

74.

Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021;11:e048391. http://bmjopen.bmj.com/content/11/3/e048391.abstract. https://doi.org/10.1136/bmjopen-2020-048391.

75.

Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US. Children and adolescents. N Engl J Med. 2020;383:334–46. https://doi.org/10.1056/NEJMoa2021680.CrossRefPubMed

76.

Parpas A, Yudd M, Dreisbach AW, Michaud J. Post COVID 19 multisystem inflammatory syndrome in an older adult. Ren Fail. 2021;43:530–2. https://doi.org/10.1080/0886022X.2021.1895839.CrossRefPubMedPubMedCentral

77.

Lechien JR, Chiesa-Estomba CM, Beckers E, Mustin V, Ducarme M, Journe F, et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021;290:451–61. https://doi.org/10.1111/joim.13209.CrossRefPubMed

78.

Paolo G. Does COVID-19 cause permanent damage to olfactory and gustatory function? Med Hypotheses. 2020;143: 110086. https://doi.org/10.1016/j.mehy.2020.110086.CrossRefPubMedPubMedCentral

79.

Cirillo N. Taste alteration in COVID-19: Significant geographical differences exist in the prevalence of the symptom. J. Infect. Public Health 2021;14:1099–105. https://www.sciencedirect.com/science/article/pii/S1876034121001891. https://doi.org/10.1016/j.jiph.2021.07.002

80.

Rodriguez B, Nansoz S, Cameron DR, Z’Graggen WJ. Is myopathy part of long-Covid? Clin Neurophysiol Off J Int Fed Clin Neurophysiol. 2021;132:1241–2. https://doi.org/10.1016/j.clinph.2021.03.008.CrossRef

81.

Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83:1118–29. https://doi.org/10.1016/j.jaad.2020.06.1016.CrossRefPubMedPubMedCentral

82.

Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. BioEssays. 2021;43: e2000331. https://doi.org/10.1002/bies.202000331.CrossRefPubMed

83.

Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. 2021;20:3315–29. https://doi.org/10.1021/acs.jproteome.1c00224.CrossRefPubMed

84.

Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021;6:255. https://doi.org/10.1038/s41392-021-00679-0.CrossRefPubMedPubMedCentral

85.

Assunção FB, Fragoso DC, Donoso Scoppetta TLP, Martins Maia AC. COVID-19-associated acute disseminated encephalomyelitis-like disease. AJNR Am J Neuroradiol. 2021;42:E21–3. https://doi.org/10.3174/ajnr.A6967.CrossRefPubMedPubMedCentral

86.

Baghbanian SM, Namazi F. Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report. Acta Neurol Belg. 2020. https://doi.org/10.1007/s13760-020-01497-x.CrossRefPubMedPubMedCentral

87.

Kim J-W, Abdullayev N, Neuneier J, Fink GR, Lehmann HC. Post-COVID-19 encephalomyelitis. Neurol Res Pract. 2021;3:18. https://doi.org/10.1186/s42466-021-00113-4.CrossRefPubMedPubMedCentral

88.

Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit Int Med J Exp Clin Res. 2021;27: e931447. https://doi.org/10.12659/MSM.931447.CrossRef

89.

Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48:2823–33. https://doi.org/10.1007/s00259-021-05215-4.CrossRefPubMedPubMedCentral

90.

Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021. https://doi.org/10.1007/s00259-021-05294-3.CrossRefPubMedPubMedCentral

91.

LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536–47. https://doi.org/10.1001/jamaneurol.2021.0504.CrossRefPubMed

92.

McCaddon A, Regland B. COVID-19: a methyl-group assault? Med Hypotheses 2021;149:110543. https://www.sciencedirect.com/science/article/pii/S030698772100061X. https://doi.org/10.1016/j.mehy.2021.110543

93.

Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. 2021;11:21. https://doi.org/10.1038/s41387-021-00163-2.CrossRefPubMedPubMedCentral

94.

Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193–9. https://doi.org/10.1007/s00592-009-0109-4.CrossRefPubMed

95.

Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11–30. https://doi.org/10.1038/s41574-020-00435-4.CrossRefPubMed

96.

Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID— metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. 2021;17:379–80. https://doi.org/10.1038/s41574-021-00495-0.CrossRefPubMedPubMedCentral

97.

Shi J, Fan J, Su Q, Yang Z. Cytokines and abnormal glucose and lipid metabolism. Front Endocrinol (Lausanne). 2019;10:703. https://doi.org/10.3389/fendo.2019.00703.CrossRef

98.

Mao Y, Xu B, Guan W, Xu D, Li F, Ren R, et al. The adrenal cortex, an underestimated site of SARS-CoV-2 infection. Front Endocrinol (Lausanne). 2020;11:593179. https://doi.org/10.3389/fendo.2020.593179.CrossRef

99.

McCracken IR, Saginc G, He L, Huseynov A, Daniels A, Fletcher S, et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation. 2021;143:865–8. https://doi.org/10.1161/CIRCULATIONAHA.120.052824.CrossRefPubMedPubMedCentral

100.

Siddiqi HK, Libby P, Ridker PM. COVID-19—a vascular disease. Trends Cardiovasc Med. 2021;31:1–5. https://doi.org/10.1016/j.tcm.2020.10.005.CrossRefPubMed

101.

Wallukat G, Hohberger B, Wenzel K, Fürst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. https://www.sciencedirect.com/science/article/pii/S2589909021000204. https://doi.org/10.1016/j.jtauto.2021.100100.

102.

Plassmeyer M, Alpan O, Corley MJ, Premeaux TA, Lillard K, Coatney P, et al. Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID. Allergy. 2021. https://doi.org/10.1111/all.14907.CrossRefPubMed

103.

Apetrii M, Enache S, Siriopol D, Burlacu A, Kanbay A, Kanbay M, et al. A brand-new cardiorenal syndrome in the COVID-19 setting. Clin Kidney J. 2020;13:291–6. https://doi.org/10.1093/ckj/sfaa082.CrossRefPubMedPubMedCentral

104.

Chun HJ, Coutavas E, Pine AB, Lee AI, Yu VL, Shallow MK, et al. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. JCI Insight. 2021. https://doi.org/10.1172/jci.insight.148476.CrossRefPubMedPubMedCentral

105.

Crestani B, Marchand-Adam S, Quesnel C, Plantier L, Borensztajn K, Marchal J, et al. Hepatocyte growth factor and lung fibrosis. Proc Am Thorac Soc. 2012;9:158–63. https://doi.org/10.1513/pats.201202-018AW.CrossRefPubMed

106.

Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2016;17:23. https://doi.org/10.1186/s12931-016-0343-6.CrossRefPubMedPubMedCentral

107.

Chan JF-W, Yip CC-Y, To KK-W, Tang TH-C, Wong SC-Y, Leung K-H, et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens. J. Clin. Microbiol. [Internet] 2020 22;58:e00310–20, /jcm/58/5/JCM.00310–20.atom. https://jcm.asm.org/content/58/5/e00310-20. https://doi.org/10.1128/JCM.00310-20.

108.

Almutairi AS, Abunurah H, Hadi Alanazi A, Alenazi F, Nagy H, Saad Almutairi N, et al. The immunological response among COVID-19 patients with acute respiratory distress syndrome. J Infect Public Health. 2021;14:954–9. https://doi.org/10.1016/j.jiph.2021.05.007.CrossRefPubMedPubMedCentral

109.

Song W-J, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9:533–44. https://doi.org/10.1016/S2213-2600(21)00125-9.CrossRefPubMedPubMedCentral

110.

Saniasiaya J, Narayanan P. Parosmia post COVID-19: an unpleasant manifestation of long COVID syndrome. Postgrad Med J. 2021. https://doi.org/10.1136/postgradmedj-2021-139855.CrossRefPubMed

111.

Brooks EF, Bhatt AS. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19? Cold Spring Harb Mol Case Stud. 2021;7:a0060310. https://doi.org/10.1101/mcs.a006031.CrossRef

112.

Guo Y, Korteweg C, McNutt MA, Gu J. Pathogenetic mechanisms of severe acute respiratory syndrome. Virus Res. 2008;133:4–12. https://doi.org/10.1016/j.virusres.2007.01.022.CrossRefPubMed

113.

Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, et al. Post-COVID-19 cholangiopathy-a new indication for liver transplantation: a case report. Transplant Proc. 2021;53:1132–7. https://doi.org/10.1016/j.transproceed.2021.03.007.CrossRefPubMedPubMedCentral

114.

Iftimie S, López-Azcona AF, Vallverdú I, Hernández-Flix S, de Febrer G, Parra S, et al. First and second waves of coronavirus disease-19: a comparative study in hospitalized patients in Reus. Spain PLoS One. 2021;16: e0248029. https://doi.org/10.1371/journal.pone.0248029.CrossRefPubMed

115.

Agostini F, Mangone M, Ruiu P, Paolucci T, Santilli V, Bernetti A. Rehabilitation setting during and after Covid-19: an overview on recommendations. J Rehabil Med. 2021;53:jrm00141. https://doi.org/10.2340/16501977-2776.CrossRefPubMed

116.

Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, et al. A clinic blueprint for post-coronavirus disease 2019 RECOVERY: learning from the past, looking to the future. Chest. 2021;159:949–58. https://doi.org/10.1016/j.chest.2020.10.067.CrossRefPubMed

117.

Parkin A, Davison J, Tarrant R, Ross D, Halpin S, Simms A, et al. A Multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. J Prim Care Community Health. 2021;12:21501327211010990. https://doi.org/10.1177/21501327211010994.CrossRef

Title: Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism
Authors: Anushri Umesh
Kumar Pranay
Ramesh Chandra Pandey
Mukesh Kumar Gupta
Publication date: 30-04-2022
Publisher: Springer Berlin Heidelberg
Keywords: Long-COVID Syndrome
COVID-19
Post-COVID Syndrome
Published in: Infection / Issue 5/2022
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-022-01835-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2022

Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy

Comparison of isolated respiratory and extrarespiratory mucormycosis: a 21-year observational study of 44 cases

Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

Combination of doxycycline, streptomycin and hydroxychloroquine for short-course treatment of brucellosis: a single-blind randomized clinical trial

SARS-2 COVID-19-induced immunity response, a new prognostic marker for the pregnant population correlates inversely with neonatal Apgar score

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials